New from NCI |
Can Acupuncture Reduce Joint Pain Caused by Breast Cancer Treatment? |
![Close-up of hand inserting acupuncture needles](https://www.cancer.gov/PublishedContent/Images/news-events/cancer-currents-blog/2018/treatment-acupuncture-article.__v20035893.jpg) |
|
A study in postmenopausal women with early-stage breast cancer tested acupuncture as a means to reduce joint pain caused by drugs called aromatase inhibitors. |
Drug Combination May Improve Outlook for Some Patients with CLL |
![Illustration demonstrating how Venetoclax blocks the action of BCL-2, a protein that prevents cell death and is often overexpressed in CLL cells.](https://www.cancer.gov/PublishedContent/Images/news-events/cancer-currents-blog/2018/bcl-2-allow-cll-evade-article.__v10080506.jpg) |
|
A recent study looked at whether a new drug combination may be an effective option for patients with chronic lymphocytic leukemia (CLL) that has stopped responding to treatment. |
Trial Aims to Decrease Early Deaths in Patients with Rare Leukemia In a unique clinical trial, oncologists with experience treating a rare leukemia are doing something simple to help clinicians at hospitals across the country treat their patients. |
Stomach Bacteria and Colon and Rectal Cancers Scientists have discovered a relationship between normal stomach bacteria and colon and rectal cancer. Learn what happened when they used antibiotics in mice with the disease to kill these bacteria.
|
PDQ Summary Updates |
Osteosarcoma and Malignant Fibrous Histiocytosis (MFH) of Bone Treatment We’ve revised our treatment summary on osteosarcoma and MFH of bone with updated information on treatment options and the treatments used for different stages of disease.
|
Drug Information Updates |
Pertuzumab Use in Breast Cancer We’ve updated our drug information summary with an expanded FDA approval. Pertuzumab is now approved for use as adjuvant therapy in patients with early-stage HER2-positive breast cancer that has a high risk of recurrence.
|